Free Trial

Insider Selling: CeriBell (NASDAQ:CBLL) CTO Sells 11,104 Shares of Stock

CeriBell logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • CTO Raymond Woo sold 11,104 shares on May 1 at an average price of $20.44 for about $226,966, trimming his position by 5.32% to 197,648 shares (≈$4.04M); he also executed multiple sales in Feb–Apr.
  • Stock action: CBLL traded down 1.1% to $20.27 on Monday with volume ~203,741, trading inside a 52‑week range of $10.85–$24.33 and 50/200‑day moving averages near $19.15/$18.55.
  • Fundamentals and analyst view: CeriBell beat quarterly revenue and EPS estimates (EPS -$0.36 vs. -$0.43) but remains unprofitable with negative margins; analysts hold a consensus "Moderate Buy" and an average price target of $23.20, while several institutions have recently adjusted their stakes.
  • Five stocks we like better than CeriBell.

CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) CTO Raymond Woo sold 11,104 shares of the stock in a transaction on Friday, May 1st. The shares were sold at an average price of $20.44, for a total value of $226,965.76. Following the completion of the sale, the chief technology officer owned 197,648 shares in the company, valued at approximately $4,039,925.12. This trade represents a 5.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Raymond Woo also recently made the following trade(s):

  • On Wednesday, April 1st, Raymond Woo sold 11,112 shares of CeriBell stock. The shares were sold at an average price of $18.56, for a total value of $206,238.72.
  • On Monday, March 2nd, Raymond Woo sold 8,087 shares of CeriBell stock. The shares were sold at an average price of $18.25, for a total value of $147,587.75.
  • On Monday, February 23rd, Raymond Woo sold 705 shares of CeriBell stock. The shares were sold at an average price of $19.79, for a total value of $13,951.95.

CeriBell Stock Down 1.1%

CBLL traded down $0.23 during trading hours on Monday, reaching $20.27. The company's stock had a trading volume of 203,741 shares, compared to its average volume of 238,853. CeriBell, Inc. has a 52 week low of $10.85 and a 52 week high of $24.33. The company's 50-day moving average is $19.15 and its 200-day moving average is $18.55. The company has a quick ratio of 9.35, a current ratio of 9.73 and a debt-to-equity ratio of 0.13.

CeriBell (NASDAQ:CBLL - Get Free Report) last posted its quarterly earnings results on Tuesday, February 24th. The company reported ($0.36) earnings per share for the quarter, beating analysts' consensus estimates of ($0.43) by $0.07. The business had revenue of $24.78 million for the quarter, compared to analysts' expectations of $23.95 million. CeriBell had a negative return on equity of 31.77% and a negative net margin of 59.97%. Sell-side analysts forecast that CeriBell, Inc. will post -1.44 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CBLL shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of CeriBell in a research report on Monday, April 6th. BTIG Research reiterated a "buy" rating and set a $30.00 price objective on shares of CeriBell in a research report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, CeriBell has an average rating of "Moderate Buy" and an average price target of $23.20.

Get Our Latest Analysis on CeriBell

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Principal Financial Group Inc. increased its position in CeriBell by 71.9% during the 1st quarter. Principal Financial Group Inc. now owns 23,180 shares of the company's stock worth $425,000 after buying an additional 9,696 shares during the period. Y Intercept Hong Kong Ltd acquired a new stake in shares of CeriBell during the 1st quarter worth $341,000. Strs Ohio acquired a new stake in shares of CeriBell during the 1st quarter worth $27,000. Caitong International Asset Management Co. Ltd grew its holdings in shares of CeriBell by 8,735.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,739 shares of the company's stock worth $60,000 after purchasing an additional 2,708 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in shares of CeriBell by 15.5% during the 4th quarter. Invesco Ltd. now owns 12,037 shares of the company's stock worth $264,000 after purchasing an additional 1,618 shares in the last quarter.

CeriBell Company Profile

(Get Free Report)

CeriBell Corp NASDAQ: CBLL is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell's solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company's product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.

Featured Stories

Insider Buying and Selling by Quarter for CeriBell (NASDAQ:CBLL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CeriBell Right Now?

Before you consider CeriBell, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CeriBell wasn't on the list.

While CeriBell currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines